Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by Country Club Bank

Country Club Bank decreased its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 1.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 9,016 shares of the company’s stock after selling 150 shares during the quarter. Country Club Bank’s holdings in Henry Schein were worth $660,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in HSIC. Wealth Enhancement Advisory Services LLC increased its stake in Henry Schein by 19.4% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 35,213 shares of the company’s stock worth $2,659,000 after acquiring an additional 5,717 shares during the last quarter. First Trust Direct Indexing L.P. grew its stake in Henry Schein by 4.2% during the 1st quarter. First Trust Direct Indexing L.P. now owns 5,356 shares of the company’s stock worth $404,000 after purchasing an additional 215 shares in the last quarter. Tempus Wealth Planning LLC grew its stake in Henry Schein by 10.0% during the 1st quarter. Tempus Wealth Planning LLC now owns 4,347 shares of the company’s stock worth $328,000 after purchasing an additional 394 shares in the last quarter. New Century Financial Group LLC grew its stake in Henry Schein by 15.7% during the 1st quarter. New Century Financial Group LLC now owns 4,575 shares of the company’s stock worth $346,000 after purchasing an additional 620 shares in the last quarter. Finally, Everett Harris & Co. CA grew its stake in Henry Schein by 13.9% during the 1st quarter. Everett Harris & Co. CA now owns 119,257 shares of the company’s stock worth $9,006,000 after purchasing an additional 14,580 shares in the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently commented on the company. UBS Group lowered their target price on Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a research note on Wednesday, August 7th. Evercore ISI boosted their target price on Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a report on Tuesday, October 8th. Baird R W raised Henry Schein from a “hold” rating to a “strong-buy” rating in a report on Monday, July 22nd. Robert W. Baird reduced their target price on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a report on Wednesday, August 7th. Finally, JPMorgan Chase & Co. reduced their target price on Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a report on Monday, August 12th. One analyst has rated the stock with a sell rating, six have given a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $77.50.

Henry Schein Stock Down 1.2 %

HSIC opened at $70.00 on Friday. The company has a quick ratio of 0.90, a current ratio of 1.55 and a debt-to-equity ratio of 0.46. The business has a 50 day moving average price of $70.57 and a two-hundred day moving average price of $69.80. Henry Schein, Inc. has a 52 week low of $60.01 and a 52 week high of $82.63. The company has a market cap of $8.87 billion, a PE ratio of 25.93, a P/E/G ratio of 2.00 and a beta of 0.86.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.22 by $0.01. The company had revenue of $3.10 billion for the quarter, compared to analysts’ expectations of $3.27 billion. Henry Schein had a return on equity of 13.19% and a net margin of 2.82%. The firm’s quarterly revenue was up .0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.31 EPS. As a group, research analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current year.

Insider Buying and Selling

In related news, SVP Lorelei Mcglynn sold 21,035 shares of the company’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the sale, the senior vice president now owns 71,833 shares in the company, valued at $4,978,026.90. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 1.14% of the company’s stock.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.